ArticleFrontiers in medicine2026

Pan-immune-inflammation value predicts 2-year recurrence after chemoradiotherapy in nasopharyngeal carcinoma.

Ke Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.